Prognostic Predictors of Response to Hypoglycemic Therapy

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 800 participants.

Also called NCT03804411

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose basic science
Phase
Phase 4
Enrolled
  • 800 participants (planned count) (from the registry)
Sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (from the registry)
Registry
  • NCT NCT03804411
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03804411. Randomized; single masking; primary purpose basic science. Start 2017-08-01 (actual); primary completion 2020-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prognostic Predictors of Response to Hypoglycemic Therapy
Condition
Diabetes Mellitus, Type 2
Intervention (Drug)
Automatic system guided treatment
Intervention (Drug)
Standard treatment
Lead sponsor
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health (class: other)

Record details

Record id
cardio:ct-nct03804411
Content hash
cfd90126218ada2b655462012f5e9ee54ec3f6a88c660c654c45ade701dd1d3b